Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Treatment of Bacterial Bronchitis

First-Line Treatment Options

  • The American College of Physicians recommends amoxicillin 500 mg three times daily for 5 days as the standard first-line treatment for bacterial bronchitis with clinical signs of bacterial infection (increased sputum purulence plus increased dyspnea and/or increased sputum volume) 1
  • For patients with beta-lactamase producing organisms, the British Thoracic Society recommends amoxicillin-clavulanate 625 mg three times daily for 5 days 2, 3
  • The treatment duration should be limited to 5 days as longer durations have not shown additional benefits in uncomplicated bacterial bronchitis, according to the American College of Physicians 1

Alternative Treatment Options

  • The British Thoracic Society recommends doxycycline 100 mg twice daily for 5 days as an effective alternative for patients with penicillin allergy 2

Treatment Considerations Based on Bacterial Pathogens

  • Common bacterial pathogens in bronchitis include Haemophilus influenzae, which can be treated with amoxicillin 500 mg three times daily (for beta-lactamase negative strains) or amoxicillin-clavulanate 625 mg three times daily (for beta-lactamase positive strains) for 5 days, according to the British Thoracic Society 2
  • Streptococcus pneumoniae can be treated with amoxicillin 500 mg three times daily for 5 days, as recommended by the British Thoracic Society 2
  • Moraxella catarrhalis can be treated with amoxicillin-clavulanate 625 mg three times daily for 5 days, according to the British Thoracic Society 2

Special Considerations

  • For patients with chronic obstructive pulmonary disease (COPD) exacerbations, antibiotic therapy is indicated when at least two of the three Anthonisen criteria are present: increased sputum volume, increased sputum purulence, and increased dyspnea, as recommended by the European Respiratory Society 3
  • In simple chronic bronchitis without obstruction, immediate antibiotic therapy is not recommended unless fever persists for more than 3 days, according to the European Respiratory Society 3
  • For patients with obstructive chronic bronchitis with chronic respiratory insufficiency, immediate antibiotic therapy is recommended, as stated by the European Respiratory Society 3

Common Pitfalls and Caveats

  • Acute uncomplicated bronchitis is typically a self-limited viral infection and antibiotics should not be initiated unless there are clear signs of bacterial infection, according to the American College of Physicians 1
  • Purulent sputum alone is not sufficient to indicate bacterial infection or need for antibiotics, as stated by the European Respiratory Society 3
  • If a patient is not improving with appropriate antibiotics, reassess for other causes rather than extending antibiotic duration, recommends the American College of Physicians 1
  • These recommendations may not apply to patients with complicated anatomy (such as bronchiectasis) or recent history of resistant bacterial infections, according to the American College of Physicians 1
  • For bronchiectasis, longer courses (14 days) are typically recommended, especially for Pseudomonas aeruginosa infections, as recommended by the British Thoracic Society 2, 4

Monitoring Response

  • Patients should show clinical improvement within 2-3 days of starting appropriate antibiotic therapy, according to the American College of Physicians 1
  • If symptoms persist beyond this timeframe, consider reevaluation for alternative diagnoses or resistant organisms, recommends the American College of Physicians 1